New evidence highlights AI’s potential in early lung cancer detection At the IASLC 2024 World Conference on Lung Cancer in San Diego, a new study has demonstrated that AI-powered chest X-ray ...

The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex The World Health Organization (WHO) has announced that it has added Bavarian Nordic’s mpox vaccine to its list of ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...

Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement of a Phase II study involving a novel molecular SPECT imaging agent, ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley, who is General Manager of Amgen UK and Ireland, has over 25 years of life ...

AstraZeneca’s Andrea Mugan shares her unique perspectives on patients, experience, change and challenges ...

This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory ...

Eli Lilly and Company has announced promising results from two phase 3 clinical trials, QWINT-1 and QWINT-3, evaluating the efficacy of once-weekly insulin efsitora alfa (efsitora) in adults with type ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Astellas Pharma’s Vyloy (zolbetuximab) as part of a first-line combination treatment for a subset of gastric cancer patients ...

The grant will support clinical trials of rare disease therapy for leukodystrophy Oxford-based SynaptixBio has been awarded a £2m BioMedical Catalyst grant from Innovate UK to support first-in-human ...

200,000 people in the UK have what is considered a ‘hidden’ lung condition Bronchiectasis is the third most common lung condition in the UK but despite this, it is sometimes seen as a ‘hidden’ disease ...